CRISPR-Cas9 Mode of Action
September 14, 1990 was the first FDA approved human clinical trial for gene therapy. The patient, then [MORE]
Nvidia’s DGX-1 Supercomputer
Imagine the look on the TSA inspector’s face when he asks if that’s a computer in your carry-on [MORE]
Microbiome
Sometime in 2017, a Cambridge, MA company, Synlogic, plans to carry out the first clinical trial using synthetic biology—which in [MORE]
Scott Huennekens, President and CEO
The piece has more titillation than information, but it describes a potential disruptive innovation in the [MORE]
Dopamine Pathways
In two more years, the idea of clinical gene therapy will be a half-century old. Yet, during this time [MORE]
Transcription Factors
Post-traumatic stress disorder, which afflicts about eight million Americans, appears to be a proteomic disease. DNA from these suffererss [MORE]
Stem Cells from Adipose Tissue
It wouldn’t come as a surprise that clinics in foreign countries are offering fraudulent (or at [MORE]
Gen9 Lab
“HGP Write” is the name of an idea more than a project in progress. Recently, a number of synthetic [MORE]
Regenerative Gel
It would be welcome news, indeed, if means existed to regenerate blood vessels in diabetics, thereby reducing the threat [MORE]
Smart Tissue Autonomous Robot
Between torn muscle repairs and hernia operations, more than 45 million soft tissue surgeries are performed in [MORE]
Kinema Pick Robot
Hospital supply managers handle an enormous range of items from delicate instruments to bed dressings, and cleaning solvents. [MORE]
Olfaction
This is a piece about innovation which hasn’t happened yet—artificial olfaction. For a very long time, researchers have been trying [MORE]
Focusing Eyeglasses
In 1987 Japanese camera maker Canon introduced its electro-optical system for autofocusing. Sensors perceived where the eye was looking [MORE]
In a remarkable feat, a French biotech company, Cellectis, used both gene editing and gene replacement technologies to engineer “universal” [MORE]